mecamylamine has been researched along with Primary Peritonitis in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, RL | 1 |
| Castanheira, FV | 1 |
| Figueiredo, JG | 1 |
| Bassi, GS | 1 |
| Ferreira, SH | 1 |
| Cunha, FQ | 1 |
| Cunha, TM | 1 |
| Kanashiro, A | 1 |
1 other study available for mecamylamine and Primary Peritonitis
| Article | Year |
|---|---|
Pharmacological Beta-Adrenergic Receptor Activation Attenuates Neutrophil Recruitment by a Mechanism Dependent on Nicotinic Receptor and the Spleen.
Topics: Adrenergic beta-Agonists; Animals; Chemotaxis, Leukocyte; Cytokines; Isoproterenol; Mecamylamine; Mi | 2016 |